Chargement en cours...
Retrospective Analysis of Medication Utilization and Clinical Outcomes in Patients With Idiopathic Pulmonary Fibrosis Treated With Nintedanib or Pirfenidone
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease which results in thickening and scarring of the interstitial tissue. As the only 2 Food and Drug Administration (FDA)-approved medications on the market, it is valuable to compare the impact of nintedanib and pirfenidone on c...
Enregistré dans:
| Publié dans: | Clin Med Insights Circ Respir Pulm Med |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
SAGE Publications
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6416683/ https://ncbi.nlm.nih.gov/pubmed/30890862 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1179548419834922 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|